Severe hypertriglyceridemia as a cause of necrotizing pancreatitis in a pediatric patient with familial hyperchylomicronemia syndrome: A case report.

Familial hyperchylomicronemia syndrome acute pancreatitis hypertriglyceridemia primary dyslipidemia

Journal

SAGE open medical case reports
ISSN: 2050-313X
Titre abrégé: SAGE Open Med Case Rep
Pays: England
ID NLM: 101638686

Informations de publication

Date de publication:
2022
Historique:
received: 14 01 2022
accepted: 09 06 2022
entrez: 15 7 2022
pubmed: 16 7 2022
medline: 16 7 2022
Statut: epublish

Résumé

Familial hyperchylomicronemia syndrome is a monogenic autosomal recessive disorder that causes severe and refractory hypertriglyceridemia. This uncommon condition is challenging to diagnose and treat and can lead to comorbidities such as acute pancreatitis. Although treatment options are limited in the pediatric population, strict diets and treatments approved for other dyslipidemias may be implemented in familial hyperchylomicronemia syndrome, given the lack of pharmacological interventions available. We report a 14-year-old female presented to the emergency room with abdominal pain suggestive of acute pancreatitis. Biochemical analysis revealed a triglyceride value of 4260 mg/dL. Treatment for triglyceride reduction with a strict CHILD-2 triglyceride-lowering diet, insulin infusion, fibrates, and multiple plasmapheresis were initially insufficient. Primary hypertriglyceridemia was suspected, and genetic testing identified a homozygous pathogenic variant in the lipoprotein lipase gene, diagnosing familial hyperchylomicronemia syndrome. She was discharged with a maximum dose of fibrate, statin, omega-3 fatty acids, and a restrictive diet. At her 1-month and 9-month follow-ups, her triglyceride values were 756 and 495 mg/dL, respectively, without incident complications. Familial hyperchylomicronemia syndrome is an uncommon condition with limited available literature and treatment options, especially in the pediatric population. Acute pancreatitis secondary to severe hypertriglyceridemia is a condition with a high risk of mortality which requires prompt clinical suspicion and treatment.

Identifiants

pubmed: 35837325
doi: 10.1177/2050313X221109972
pii: 10.1177_2050313X221109972
pmc: PMC9274426
doi:

Types de publication

Case Reports

Langues

eng

Pagination

2050313X221109972

Informations de copyright

© The Author(s) 2022.

Déclaration de conflit d'intérêts

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

Endocr Pract. 2018 Sep;24(9):789-795
pubmed: 30084679
J Clin Lipidol. 2015 Sep-Oct;9(5 Suppl):S20-8
pubmed: 26343209
Atherosclerosis. 2018 Aug;275:265-272
pubmed: 29980054
N Engl J Med. 2012 Mar 22;366(12):1154-5
pubmed: 22435375
Endocrine. 2021 Feb;71(2):344-350
pubmed: 33006726
Clin Chim Acta. 2020 Apr;503:19-34
pubmed: 31923423
Curr Pediatr Rev. 2017;13(4):225-231
pubmed: 29345595
J Clin Lipidol. 2018 Mar - Apr;12(2):305-310
pubmed: 29454679
N Engl J Med. 1981 Aug 27;305(9):515-7
pubmed: 6265781
Trends Cardiovasc Med. 2020 Feb;30(2):80-85
pubmed: 31003756
J Clin Apher. 2010;25(3):83-177
pubmed: 20568098
Atherosclerosis. 2019 Apr;283:137-142
pubmed: 30655019
Front Endocrinol (Lausanne). 2020 Oct 23;11:593931
pubmed: 33193106
Drug Des Devel Ther. 2020 Jul 06;14:2623-2636
pubmed: 32753844

Auteurs

Laura Valenzuela-Vallejo (L)

School of Medicine and Health Sciences-Universidad del Rosario, Bogotá, Colombia.
Endocrinology Department, Fundación Cardioinfantil, Instituto de Cardiología, Bogotá, Colombia.

Daniela Meléndrez-Vásquez (D)

School of Medicine and Health Sciences-Universidad del Rosario, Bogotá, Colombia.
Endocrinology Department, Fundación Cardioinfantil, Instituto de Cardiología, Bogotá, Colombia.

Paola Durán-Ventura (P)

Pediatric Endocrinologist, Pediatrics Endocrinology Department, Fundación Cardioinfantil-Instituto de Cardiología, Bogotá, Colombia.
School of Medicine and Health Sciences-Universidad del Rosario, Bogotá, Colombia.

Carolina Rivera-Nieto (C)

School of Medicine and Health Sciences-Universidad del Rosario, Bogotá, Colombia.
Genetics Department, Fundación Cardioinfantil-Instituto de Cardiología, Bogotá, Colombia.

Adriana Lema (A)

Pediatric Endocrinologist, Pediatrics Endocrinology Department, Fundación Cardioinfantil-Instituto de Cardiología, Bogotá, Colombia.
School of Medicine and Health Sciences-Universidad del Rosario, Bogotá, Colombia.

Monica Fernandez (M)

Pediatric Endocrinologist, Pediatrics Endocrinology Department, Fundación Cardioinfantil-Instituto de Cardiología, Bogotá, Colombia.
School of Medicine and Health Sciences-Universidad del Rosario, Bogotá, Colombia.

Classifications MeSH